Medical research

Project aims to achieve cell-based heart repair

Chronic heart failure—also known as cardiac insufficiency in medicine—is the most common reason for hospital admissions and one of the most frequent causes of death in the western world. In Germany alone, 4 million people ...

Medications

Survival benefit seen with triple therapy for severe COVID-19

For patients with severe COVID-19 requiring high flow nasal cannula (HFNC), triple therapy of dexamethasone, remdesivir, and baricitinib is associated with significant survival benefit compared with dual therapy, according ...

page 6 from 21